Green Thumb Industries GTBIF
OTC GTBIF
$7.62 +0.37 (+5.10%)
At close: Aug 19, 2026 · 3:59 PM UTC

Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026)

Green Thumb Industries' (GTBIF) quarterly Cash from Financing Activities came in at $5.7 million in Q1 2026, up 219.97% YoY from $1.8 million in Q1 2025, and up 127.02% on a QoQ basis from -$21.1 million in Q4 2025.

Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Green Thumb Industries (GTBIF) has 8 years of Cash from Financing Activities data on file, last reported at $5.7 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 219.97% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.5 million (up 54.46% YoY) and the FY2025 annual result came in at -$50.9 million, up 46.71% from the prior year.
  • Cash from Financing Activities improved to $5.7 million in Q1 2026, from -$21.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.9 million in Q4 2022 to a low of -$51.1 million in Q3 2024.
  • A 5-year average of -$8.5 million and a median of -$5.8 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 10420.0% — and 2024, when it slumped 8320.59%.
  • Tracing GTBIF's Cash from Financing Activities over 5 years: stood at $18.9 million in 2022, then plunged by 130.97% to -$5.8 million in 2023, then tumbled by 57.38% to -$9.2 million in 2024, then plunged by 129.8% to -$21.1 million in 2025, then surged by 127.02% to $5.7 million in 2026.
  • The last three Cash from Financing Activities figures came in at $5.7 million (Q1 2026), -$21.1 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn -1.00 Mn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Green Thumb Industries 1.65 Bn 1.37 Bn 137.87 Mn -57.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.66 Mn
Jun 30, 2026 -57.66 Mn
Mar 31, 2026 5.71 Mn
Mar 31, 2026 5.71 Mn
Dec 31, 2025 -21.12 Mn
Dec 31, 2025 -21.12 Mn
Sep 30, 2025 -2.63 Mn
Sep 30, 2025 -2.63 Mn
Jun 30, 2025 -22.43 Mn
Jun 30, 2025 -22.43 Mn
Mar 31, 2025 -4.76 Mn
Mar 31, 2025 -4.76 Mn
Dec 31, 2024 -9.19 Mn
Dec 31, 2024 -9.19 Mn
Sep 30, 2024 -51.06 Mn
Sep 30, 2024 -51.06 Mn
Jun 30, 2024 -23.89 Mn
Jun 30, 2024 -23.89 Mn
Mar 31, 2024 -11.45 Mn
Mar 31, 2024 -11.45 Mn